Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 25;11(5):601-610.
eCollection 2021.

Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study

Nilay Solanki  1 , Dhruvi Pandit  1 , Shubha Desai  2
Affiliations

Effectiveness and safety assessment of beta-blockers, calcium channel blockers, and angiotensin receptor blockers in hypertensive patients: a prospective study

Nilay Solanki et al. Am J Cardiovasc Dis. .

Abstract

Background: Hypertension is most common prevailing cardiovascular disease worldwide. In this condition the effectiveness and safety of already available and many time-tested medications should be regularly reviewed.

Methodology: Ethical approval of study was obtained from human research ethics committee of the hospital. 180 patients were enrolled with three groups of antihypertensive medication groups as calcium channel blocker (amlodipine), beta blocker (metoprolol) and angiotensin receptor blocker (telmisartan) over a span of eight months. The data was obtained from week zero to twelve (SBP: Systolic Blood Pressure and DBP: Diastolic Blood Pressure). Safety of Beta blocker, calcium channel blocker and angiotensin receptor blocker were investigated.

Results: Comparison of efficacy between the beta blocker, calcium channel blocker and angiotensin blocker receptor blocker were shown to be non-significant. It indicated that all drug therapies have the same successful reduction of SBP (P-0.4819). No significant adverse reactions were observed in either class of the medicines.

Conclusion: The study showed the efficacy of Calcium Channel Blocker, Beta Blocker and Angiotensin Receptor Blocker in reduction of SBP & DBP was same, while Calcium Channel Blockers were superior to other two medications.

Keywords: Calcium channel blocker; angiotensin receptor blocker; beta blocker; efficacy; safety.

PubMed Disclaimer

Conflict of interest statement

None.

References

    1. Lackland DT, Weber MA. Global burden of cardiovascular disease and stroke: hypertension at the core. Can J Cardiol. 2015;315:569–71. - PubMed
    1. Daniels SR, Kimball TR, Khoury P, Witt S, Morrison JA. Correlates of the hemodynamic determinants of blood pressure. Hypertension. 1996;28:37–41. - PubMed
    1. Nakkeeran M, Periasamy S, Inmozhi SR, Ramya P. Oxidative stress, antioxidant status and Hs-CRP levels in essential hypertension. IOSR J of Den and Med Sci. 2017;16:100–103.
    1. Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet. 2015;386:801–12. - PubMed
    1. Kasper D, Fauci A, Hauser S. 2012. Harrison’s principle of internal medicine 19th edition; pp. 15–25.

LinkOut - more resources